| Literature DB >> 36135618 |
Maxime Poirier1,2, Cindy Hugot1,2, Madeleine Spatz1,2, Gregory Da Costa1,2, Alexia Lapiere1,2, Chloé Michaudel1,2, Camille Danne1,2, Valérie Martin3, Philippe Langella1,2, Marie-Laure Michel1,2, Harry Sokol1,2,4, Patrick Boyaval3, Mathias L Richard1,2.
Abstract
Food processes use different microorganisms, from bacteria to fungi. Yeast strains have been extensively studied, especially Saccharomyces cerevisiae. However, to date, very little is known about the potential beneficial effects of molds on gut health as part of gut microbiota. We undertook a comprehensive characterization of five mold strains, Penicillium camemberti, P. nalgiovense, P. roqueforti, Fusarium domesticum, and Geotrichum candidum used in food processes, on their ability to trigger or protect intestinal inflammation using in vitro human cell models and in vivo susceptibility to sodium dextran sulfate-induced colitis. Comparison of spore adhesion to epithelial cells showed a very wide disparity in results, with F. domesticum and P. roqueforti being the two extremes, with almost no adhesion and 20% adhesion, respectively. Interaction with human immune cells showed mild pro-inflammatory properties of all Penicillium strains and no effect of the others. However, the potential anti-inflammatory abilities detected for G. candidum in vitro were not confirmed in vivo after oral gavage to mice before and during induced colitis. According to the different series of experiments carried out in this study, the impact of the spores of these molds used in food production is limited, with no specific beneficial or harmful effect on the gut.Entities:
Keywords: gut microbiota; inflammatory bowel disease; molds
Year: 2022 PMID: 36135618 PMCID: PMC9504484 DOI: 10.3390/jof8090893
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Primer sequences of the amplified target.
| Name | 5′–Forward–3′ | 5′–Reverse–3′ |
|---|---|---|
| GAPDH | AACTTTGGCATTGTGGAAGG | ACACATTGGGGGTAGGAACA |
| IL-10 | AGAAGCATGGCCCAGAAATCA | GGCCTTGTAGACACCTTGGT |
| IL-6 | GTAGCTATGGTACTCCAGAAGAC | ACGATGATGCACTTGCAGAA |
| INF-γ | CCATCCTTTTGCCAGTTCCTC | ATGAACGCTACACACTGCATC |
| TNF-α | GACCCTCACACTCAGATCATCTTCT | CCACTTGGTGGTTTGCTACGA |
| TEF1a | GATTTCATCAAGAACATGAT | GACGTTGAAACCGACGTTGTC |
Disease activity index calculation table.
| Score | Consistency Stool | Blood |
|---|---|---|
| 0 | Normal | Negative (−) |
| 2 | Loose stools | + |
| 4 | Diarrhea | Bleeding |
Figure 1Adhesion properties between filamentous strains. Adherence capacity of Penicillium camemberti (P. cam), P. nalgiovense (P. nal), P. roqueforti (P. roq), Fusarium domesticum (F. dom), or Geotrichum candidum (G. can) on (A) Caco-2, (B) HT29-MTX, and (C) both cell lines. * p < 0.05, ** p < 0.01, *** p < 0.001.
Figure 2IL-8 production between filamentous strains. IL-8 production by HT29 after co-culture with filamentous strains Penicillium camemberti (P. cam), P. nalgiovense (P. nal), P. roqueforti (P. roq), Fusarium domesticum (F. dom), or Geotrichum candidum (G. can) at MOI1 and MOI5, (A) without or (B) with TNF-α priming. For statistical comparisons, (*) indicates versus DMEM. * p < 0.05.
Figure 3Human immune cells differentially recognize fungal spores. Ratio of TNF-α/IL-10 production of the culture supernatants of peripheral blood mononuclear cells (PBMCs) co-incubated with Penicillium camemberti (P. cam), P. nalgiovense (P. nal), P. roqueforti (P. roq), Fusarium domesticum (F. dom), or Geotrichum candidum (G. can) for 24 h at MOI5. For statistical comparisons, (*) indicates versus RPMI. * p < 0.05, *** p < 0.001.
Figure 4Dextran sodium sulfate (DSS)-induced colitis is not influenced by fungal spores’ colonization. (A–F) Mice received vehicle (Veh, PBS), Penicillium camemberti (P. cam), P. nalgiovense (P. nal), P. roqueforti (P. roq), Fusarium domesticum (F. dom), or Geotrichum candidum (G. can) for 7 days and then dextran sulfate sodium (DSS) for 7 days. Vehicle n = 23, P. cam n = 25, P. nal n = 22, P. roq n = 24, F. dom n = 26, G. can n = 24. A. Experimental design for the administration of DSS. B. Weight of DSS-exposed mice. C. Disease activity index (DAI) of DSS-exposed mice. D. Length of the colons of mice treated with DSS. E. Intestinal inflammation, expressed as the lipocalin levels in feces at Day 7 and Day 12. F. Intestinal cytokines IL-6, TNF-α, IFN-γ, and IL-10 in the colon (qPCR). For statistical comparisons, (*) indicates versus vehicle. * p < 0.05, ** p < 0.01, *** p < 0.001.